Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells

[1]  Peter A. Jones,et al.  Cancer epigenetics: modifications, screening, and therapy. , 2008 .

[2]  B. Davidson,et al.  RNA polymerase III transcribes human microRNAs , 2006, Nature Structural &Molecular Biology.

[3]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[4]  B. Monia,et al.  Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells , 2006, Cancer biology & therapy.

[5]  A. Huwiler,et al.  Antisense targeting of Mcl-1 has therapeutic potential in gastric cancer , 2006, Cancer biology & therapy.

[6]  C. Croce,et al.  MicroRNAs and chromosomal abnormalities in cancer cells , 2006, Oncogene.

[7]  Peter A. Jones,et al.  Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells , 2006, Cell cycle.

[8]  Peter A. Jones,et al.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.

[9]  Ligang Wu,et al.  MicroRNAs direct rapid deadenylation of mRNA. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Pasquinelli,et al.  Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.

[11]  G. Gores,et al.  Mcl-1 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Human Cholangiocarcinoma Cells , 2004, Cancer Research.

[12]  V. Babich,et al.  Clusters of regulatory signals for RNA polymerase II transcription associated with Alu family repeats and CpG islands in human promoters. , 2004, Genomics.

[13]  D. Bartel,et al.  MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.

[14]  J. Issa,et al.  Enrichment for Histone H3 Lysine 9 Methylation at Alu Repeats in Human Cells* , 2003, Journal of Biological Chemistry.

[15]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[16]  O. Katoh,et al.  Increased MCL–1 Expression Is Associated with Poor Prognosis in Ovarian Carcinomas , 2002, Japanese journal of cancer research : Gann.

[17]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[18]  R. Craig,et al.  Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. , 1997, Blood.

[19]  John Calvin Reed,et al.  Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. , 1996, The American journal of pathology.

[20]  C. Schmid,et al.  Alu transcripts: cytoplasmic localisation and regulation by DNA methylation. , 1994, Nucleic acids research.

[21]  R. Craig,et al.  MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Atsushi Ochiai,et al.  Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. , 1985, Japanese journal of cancer research : Gann.

[23]  Peter A. Jones,et al.  Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.

[24]  R. Aharonov,et al.  Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.

[25]  前田 佳彦.  Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma , 2005 .

[26]  M. Suzuki,et al.  Monochloramine induced DNA fragmentation in gastric cell line MKN45. , 1998, The American journal of physiology.